Compare SHASUN PHARMA with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA J.B.CHEMICALS SHASUN PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 123.9 16.4 753.8% View Chart
P/BV x 8.5 2.3 375.8% View Chart
Dividend Yield % 0.2 0.5 45.0%  

Financials

 SHASUN PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
J.B.CHEMICALS
Mar-18
SHASUN PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs94363 25.9%   
Low Rs46255 17.9%   
Sales per share (Unadj.) Rs214.2169.1 126.6%  
Earnings per share (Unadj.) Rs5.316.6 32.1%  
Cash flow per share (Unadj.) Rs15.823.4 67.6%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %1.40.6 221.1%  
Book value per share (Unadj.) Rs53.3172.5 30.9%  
Shares outstanding (eoy) m56.6283.57 67.8%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.31.8 17.9%   
Avg P/E ratio x13.118.6 70.4%  
P/CF ratio (eoy) x4.413.2 33.5%  
Price / Book Value ratio x1.31.8 73.1%  
Dividend payout %18.712.0 155.5%   
Avg Mkt Cap Rs m3,95825,827 15.3%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m2,1642,511 86.2%   
Avg. sales/employee Rs ThNM3,747.4-  
Avg. wages/employee Rs ThNM665.7-  
Avg. net profit/employee Rs ThNM367.8-  
INCOME DATA
Net Sales Rs m12,12714,135 85.8%  
Other income Rs m229366 62.7%   
Total revenues Rs m12,35614,501 85.2%   
Gross profit Rs m1,0092,178 46.3%  
Depreciation Rs m594570 104.2%   
Interest Rs m41535 1,189.4%   
Profit before tax Rs m2301,940 11.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73552 -13.2%   
Profit after tax Rs m3021,387 21.8%  
Gross profit margin %8.315.4 54.0%  
Effective tax rate %-31.728.5 -111.2%   
Net profit margin %2.59.8 25.4%  
BALANCE SHEET DATA
Current assets Rs m6,88410,470 65.8%   
Current liabilities Rs m8,4562,749 307.6%   
Net working cap to sales %-13.054.6 -23.7%  
Current ratio x0.83.8 21.4%  
Inventory Days Days6255 111.7%  
Debtors Days Days10878 138.5%  
Net fixed assets Rs m4,9705,811 85.5%   
Share capital Rs m113167 67.8%   
"Free" reserves Rs m2,87514,248 20.2%   
Net worth Rs m3,02014,416 21.0%   
Long term debt Rs m1,8170-   
Total assets Rs m13,34717,649 75.6%  
Interest coverage x1.656.6 2.7%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.90.8 113.4%   
Return on assets %5.48.1 66.7%  
Return on equity %10.09.6 104.0%  
Return on capital %13.313.7 97.3%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,8436,164 94.8%   
Fx outflow Rs m2,1731,334 162.9%   
Net fx Rs m3,6694,829 76.0%   
CASH FLOW
From Operations Rs m3981,231 32.3%  
From Investments Rs m-1,635-208 785.7%  
From Financial Activity Rs m1,309-595 -219.9%  
Net Cashflow Rs m71427 16.7%  

Share Holding

Indian Promoters % 39.2 55.4 70.8%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 3.6 3.4 106.2%  
FIIs % 17.6 3.9 451.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 37.0 107.0%  
Shareholders   20,750 30,437 68.2%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Rally; Sensex Zooms 1,250 Points(12:30 pm)

Share markets in India are presently trading on a strong note, cheering the government's move to cut corporate tax rates to boost economic growth.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS